S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow‐up

SummaryBasal cell carcinoma (BCC) is the most common malignant tumor among fair‐skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic litera...

Full description

Saved in:
Bibliographic Details
Published in:Journal der Deutschen Dermatologischen Gesellschaft 2019-02, Vol.17 (2), p.214-230
Main Authors: Lang, Berenice M., Balermpas, Panagiotis, Bauer, Andrea, Blum, Andreas, Brölsch, G. Felix, Dirschka, Thomas, Follmann, Markus, Frank, Jorge, Frerich, Bernhard, Fritz, Klaus, Hauschild, Axel, Heindl, Ludwig M., Howaldt, Hans‐Peter, Ihrler, Stephan, Kakkassery, Vinodh, Klumpp, Bernhard, Krause‐Bergmann, Albrecht, Löser, Christoph, Meissner, Markus, Sachse, Michael M., Schlaak, Max, Schön, Michael P., Tischendorf, Lutz, Tronnier, Michael, Vordermark, Dirk, Welzel, Julia, Weichenthal, Michael, Wiegand, Susanne, Kaufmann, Roland, Grabbe, Stephan
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Basal cell carcinoma
Carcinoma, Basal Cell - epidemiology
Carcinoma, Basal Cell - pathology
Carcinoma, Basal Cell - prevention & control
Carcinoma, Basal Cell - therapy
Disease Management
Follow-Up Studies
Germany - epidemiology
Humans
Incidence
Managed Care Programs - standards
Middle Aged
Neoplasm Recurrence, Local - epidemiology
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - prevention & control
Patients
Practice Guidelines as Topic
Quality of Health Care - standards
Risk Assessment
Skin
Skin cancer
Skin Neoplasms - epidemiology
Skin Neoplasms - pathology
Skin Neoplasms - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SummaryBasal cell carcinoma (BCC) is the most common malignant tumor among fair‐skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow‐up of patients with basal cell carcinoma.
ISSN:1610-0379
1610-0387
DOI:10.1111/ddg.13755